25/250 SP 343 (Parcopa 25 mg / 250 mg)
Generic Name: carbidopa/levodopa
Pill imprint 25/250 SP 343 has been identified as Parcopa 25 mg / 250 mg.
Parcopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; restless legs syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Parcopa 25 mg / 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 25/250 SP 343 (Parcopa 25 mg / 250 mg)
- Generic Name:
- 25 mg / 250 mg
- 14.00 mm
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Schwarz Pharma
- National Drug Code (NDC):
- Inactive Ingredients:
natural mint flavor
artificial mint flavor
FD&C Blue No. 2 Aluminium Lake
|NDC Code||Manufacturer / Repackager|
|18860-0343||Azur Pharma Inc|
Note: Inactive ingredients may vary.
Parcopa is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...